Because there are always downsides
One such treatment is retatrutide, which is currently undergoing clinical research to evaluate its effectiveness within structured, medically supervised weight management programs
Packaging, Shipping & Chain of Custody Primary container: Type I borosilicate, compatible closure, tamper evidence
In Phase 2 trials, participants on higher doses experienced average weight losses of more than 20% of body weight over 48 weeks, with a high proportion achieving large reductions in weight
For more perspective, see Tonums blog post on natural alternatives to Ozempic and the Tonum motus study resources to discuss with your clinician
Those who succeed often had less total weight to lose or demonstrate exceptional adherence to diet and exercise protocols